AstraZeneca COVID-19 vaccine information could also be outdated, US security board says

0
47



An impartial group of medical consultants within the U.S. has raised issues that AstraZeneca might have launched “outdated” information on its COVID-19 vaccine.

AstraZeneca introduced on Monday (March 22) that its coronavirus vaccine was 79% efficient at stopping symptomatic COVID-19 and 100% efficient at stopping extreme or important sickness and hospitalization in a late-stage trial carried out within the U.S. that concerned greater than 32,000 volunteers. 

LEAVE A REPLY

Please enter your comment!
Please enter your name here